Company Urteste S.A.

Equities

URT

PLURTST00010

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 16:55:55 31/05/2024 BST			5-day change	1st Jan Change
93.8 ^PLN	-.--%		-.--%	-13.94%

05-28	Urteste S.A. Successfully Develops A Prototype Urine-Based Diagnostic Test for Detecting Brain Tumours	CI
2021	Urteste S.A. has completed an IPO in the amount of PLN 9.52 million.	CI

Urteste SA is a Poland-based company mainly engaged in the biotechnology sector. The Company operates in the field of medical devices for in vitro application in the field of cancer diagnostics. The technology developed by the Company involves the detection of cancer by measuring the activity of enzymes in a urine sample, using diagnostic tests that enable the detection of common cancers in their early stages. The Company offers tests for the detection of cancers such as, pancreatic cancer, prostate cancer, colorectal cancer, lung cancer, kidney cancer, liver cancer, biliary tract cancer, stomach cancer, esophageal cancer, ovarian cancer, endometrial cancer, breast cancer, leukemia, lymphoma, glioma.

Number of employees: 1

PLN in Million	2021	Weight	2022	Weight	Delta
Innovations in Biotechnology 100.0 %	0	nan %	0	100.0 %	-

PLN in Million	2021	Weight	2022	Weight	Delta
Poland 100.0 %	0	nan %	0	100.0 %	-

Managers	Title	Age	Since
Grzegorz Stefanski CEO	Chief Executive Officer	54	15/02/21
Tomasz Jan Kostuch PRN	Corporate Officer/Principal	54	15/02/21

Members of the board	Title	Age	Since
Maciej Wlodzimierz Matusiak BRD	Director/Board Member	57	28/06/22
Slawomir Kosciak BRD	Director/Board Member	40	25/04/21
Magdalena Wysocka BRD	Director/Board Member	45	25/04/21
Jaroslaw Bilinski BRD	Director/Board Member	-	-
Grzegorz Basak BRD	Director/Board Member	-	28/06/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,409,669	383,510 ( 27.21 %)	0	27.21 %

Name	Equities	%	Valuation
Allianz Polska TFI SA 1.646 %	23,200	1.646 %	560 749 zł

Urteste SA

ul. Starodworska 1

80-137, Gdansk

http://urteste.eu

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
URTESTE S.A.	-13.94%	33.55M
MODERNA, INC.	+43.36%	54.64B
IQVIA HOLDINGS INC.	-5.31%	39.92B
LONZA GROUP AG	+37.52%	38.82B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
BIO-TECHNE CORPORATION	+0.04%	12.16B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B

Other Biotechnology & Medical Research